http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103142868-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89d8e7355750aa815842a3fa5b382c19 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate | 2013-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bed5a843c078b431db89ddbdc8c3517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d4cdbd43cab1469b87c71d902ea15a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aef26e2c0b662ada743391b72f4b8bae |
publicationDate | 2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103142868-B |
titleOfInvention | Medicine for inhibiting protein-tyrosine-phosphatase-1B |
abstract | The invention discloses a medicine for inhibiting protein-tyrosine-phosphatase-1B. The medicine is characterized in that the medicine is composed of the components in weight percentage: 25.5-30.6% of tu-chung, 27.6-33.5% of gastrodia elata, 28.2-37.3% of field mint, and 18.7-25.3% of sandalwood. The preparation method of the medicine is a common preparation method and comprises the steps of crushing, mixing, and preparing powder or other pharmaceutical formulation. The experiment proves that the medicine for inhibiting the PTP-1B can effectively reduce the plasma PTP-1B content of rat in diabetes mellitus and inhibit the activity, and can effectively reduce the blood sugar level of the rat in diabetes mellitus. |
priorityDate | 2013-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 214.